BiotechTubeBiotechTube
BrainEver

BrainEver

Pre-clinical
Paris, FranceFounded 2005brainever.fr

Developing hEN1 & hOTX2 homeoproteins to halt ALS (Charcot), Parkinson’s & Retina. Secures €33M Series B. View pipeline.

Founded
2005
Focus
Biologics

About

Developing hEN1 & hOTX2 homeoproteins to halt ALS (Charcot), Parkinson’s & Retina. Secures €33M Series B. View pipeline.

Funding History

1

Total raised: $2.5M

Seed$2.5MUndisclosedJun 15, 2021

Company Info

TypePrivate
Founded2005
LocationParis, France
StagePre-clinical

Contact

brainever.fr

Sectors

Biologics / BiosimilarsNeuroscience & CNS
SIMILAR COMPANIES
4P-Pharma
4P-Pharma
Phase 2 · Lille
Patheon
Patheon
Pre-clinical · Lyon
ABL Diagnostics
ABL Diagnostics
Pre-clinical · Strasbourg
Acticor Biotech
Acticor Biotech
Pre-clinical · Paris
Adjuvatis
Adjuvatis
Pre-clinical · Lyon
Is this your company?

Claim your profile to update information, add pipeline data, and connect with investors.

Claim profile